Cargando…
Economic impact of antimicrobial resistance.
One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial-drug resistance is imprecise and incomplete. Stud...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631707/ https://www.ncbi.nlm.nih.gov/pubmed/11294725 |
_version_ | 1782163966455185408 |
---|---|
author | McGowan, J E |
author_facet | McGowan, J E |
author_sort | McGowan, J E |
collection | PubMed |
description | One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial-drug resistance is imprecise and incomplete. Studies to describe and evaluate the problem will have to employ new methods and be of large scale to produce information that is broadly applicable. |
format | Text |
id | pubmed-2631707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-26317072009-05-20 Economic impact of antimicrobial resistance. McGowan, J E Emerg Infect Dis Research Article One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial-drug resistance is imprecise and incomplete. Studies to describe and evaluate the problem will have to employ new methods and be of large scale to produce information that is broadly applicable. Centers for Disease Control and Prevention 2001 /pmc/articles/PMC2631707/ /pubmed/11294725 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Article McGowan, J E Economic impact of antimicrobial resistance. |
title | Economic impact of antimicrobial resistance. |
title_full | Economic impact of antimicrobial resistance. |
title_fullStr | Economic impact of antimicrobial resistance. |
title_full_unstemmed | Economic impact of antimicrobial resistance. |
title_short | Economic impact of antimicrobial resistance. |
title_sort | economic impact of antimicrobial resistance. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631707/ https://www.ncbi.nlm.nih.gov/pubmed/11294725 |
work_keys_str_mv | AT mcgowanje economicimpactofantimicrobialresistance |